Sour diesel - This type of medicinal marijuana is a sativa-dominant strain. Sour Diesel, also known as Sour D, is a fast-acting strain that induces energizing, dreamy cerebral effects. This strain is best known for its anti-depressant properties and pain-relieving effects.
Candyland - This strain's strong sativa genetics provide users with an uplifting and stimulating effect. Candyland is found to relieve pain and reduce muscle tension. This strain won a gold medal at the 2012 KushCon.
White Widow - The white widow strain was originally developed in the Netherlands. This balanced hybrid is characterized by its buds that contain frost white resin, which indicate the strain's potency. The strain is found to produce an energetic euphoria that helps the body attain full relaxation. White widow is known to manage even severe forms of migraine.
Cannatonic - This strain is known for having low levels of tetrahydrocannabinol, a molecule associated with the mind-altering effects of marijuana.On the other hand, cannatonic is known to contain high levels of cannabidiol, a cannabis compound that shows a wide range of potential in medical use. The strain is shown to produce a relaxing and uplifting effect. Cannatonic is among the best known medicinal marijuana strains due to its efficacy in pain management with little to no psychoactive effects.
Hawaiian dream - This strain is also found to have high cannabidiol levels. Hawaiian dream does not induce brain fog, which makes it an ideal migraine treatment.
Migraines and medicinal marijuana
According to the Migraine Research Foundation (MRF), migraine is currently the third most common illness, and the sixth most disabling condition worldwide. The condition affects 18% of women, 6% of men, and 10% of children in the U.S. Migraine is more common in adults at ages 25 to 55 years old. MRF data also show that more than four million U.S. adults currently suffer from chronic daily migraine.
A study published in the journal Pharmacotherapy revealed that patients experienced fewer migraines and decreased frequency following marijuana treatment. A Care By Design survey also showed that 100% of participants with migraines reported marked reductions in pain and discomfort after taking medicinal cannabis. Another meta-analysis confirmed that medicinal cannabis and cannabinoids show potential in the treatment of chronic pain and migraine. These findings were published in the journal Headache.
To use or not to use?
Marijuana use remains to be a controversial topic within the health care community despite being legalized in 28 states and the Washington D.C. Data from two National Institute on Alcohol Abuse and Alcoholism surveys revealed that marijuana use has more than doubled over the last 10 years. According to the surveys, cannabis use among American adults grew from 4.1 percent in the 2001-2002 period to 9.5 percent in the 2012-2013 period.
Mounting evidence on the beneficial effects of medicinal marijuana has prompted a vast majority physicians worldwide to consider prescribing the compound. A survey of 1,446 doctors from 72 different countries showed that 76 percent were in favor of cannabis use for medical purposes. The findings were published in the New England Journal of Medicine.